User:Mr. Ibrahem/Secukinumab

Secukinumab, sold under the brand name Cosentyx, is a medication used to treat psoriasis, ankylosing spondylitis, and psoriatic arthritis. It is given by injection under the skin.

Common side effects include a runny nose, diarrhea, cold sores, and hives. Other side effects may include anaphylaxis and infection. Use during pregnancy or breastfeeding is not recommended. It is a monoclonal antibody that binds to and inhibits interleukin (IL)-17A.

Secukinumab was approved for medical use in the United States and Europe in 2015. In the United Kingdom 150 mg costs the NHS about £600 as of 2021. This amount in the United States costs about 6,200 USD.